169 related articles for article (PubMed ID: 33533201)
1. A validated method for the quantification of IOX-2, a potent prolyl hydroxylase inhibitor in equine urine and plasma using liquid chromatography-high-resolution mass spectrometry.
Mikhail E; Siccardi E; Bawazir A; Rajesh A; Prathyush S; Al Wazani DMK; Sabeek M; John T
Drug Test Anal; 2021 Jun; 13(6):1178-1190. PubMed ID: 33533201
[TBL] [Abstract][Full Text] [Related]
2. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
[TBL] [Abstract][Full Text] [Related]
3. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive metabolic study of nicotine in equine plasma and urine using liquid chromatography/high-resolution mass spectrometry for the identification of unique biomarkers for doping control.
Ishii H; Leung GN; Yamashita S; Nagata SI; Kushiro A; Sakai S; Toju K; Okada J; Kawasaki K; Kusano K; Kijima-Suda I
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1190():123100. PubMed ID: 35032890
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high-resolution mass spectrometry.
Uchida T; Kisugi T; Ishii H; Yamada M; Kinoshita K; Leung GN
Rapid Commun Mass Spectrom; 2024 Sep; 38(17):e9856. PubMed ID: 38945695
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometer for the purpose of doping control.
Ishii H; Shibuya M; So YM; Wong JKY; Ho ENM; Kusano K; Sone Y; Kamiya T; Wakuno A; Ito H; Miyata K; Yamada M; Leung GN
Drug Test Anal; 2022 Feb; 14(2):233-251. PubMed ID: 34612014
[TBL] [Abstract][Full Text] [Related]
8. Doping control analysis of 121 prohibited substances in equine hair by liquid chromatography-tandem mass spectrometry.
Wong JKY; Choi TLS; Kwok KY; Lei ENY; Wan TSM
J Pharm Biomed Anal; 2018 Sep; 158():189-203. PubMed ID: 29885604
[TBL] [Abstract][Full Text] [Related]
9. Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry for doping control.
Ishii H; Shibuya M; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2021 Mar; 35(5):e9028. PubMed ID: 33319421
[TBL] [Abstract][Full Text] [Related]
10. Detection, quantification, and identification of dermorphin in equine plasma and urine by LC-MS/MS for doping control.
Guan F; Uboh CE; Soma LR; Robinson M; Maylin GA; Li X
Anal Bioanal Chem; 2013 May; 405(14):4707-17. PubMed ID: 23571464
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma.
Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():1-7. PubMed ID: 26143477
[TBL] [Abstract][Full Text] [Related]
12. Detection of bioactive peptides including gonadotrophin-releasing factors (GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC/HRMS).
Kwok KY; Choi TLS; Kwok WH; Lau MY; Leung EMK; Leung GNW; Wong JKY; Wan TSM; Adrian FF; Prabhu A; Ho ENM
Drug Test Anal; 2020 Sep; 12(9):1274-1286. PubMed ID: 32558326
[TBL] [Abstract][Full Text] [Related]
13. Analysis of metronidazole in equine plasma using liquid chromatography/tandem mass spectrometry and high-resolution accurate mass spectrometry.
Ilomuanya M; Uboh C; Ciallella J; Li X; Liu Y; Ifudu N; Azubuike C; Igwilo C
Rapid Commun Mass Spectrom; 2015 Apr; 29(8):753-63. PubMed ID: 26406490
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-tandem mass spectrometry.
Wang CC; Hartmann-Fischbach P; Krueger TR; Wells TL; Feineman AR; Compton JC
J Anal Toxicol; 2012 Jun; 36(5):327-33. PubMed ID: 22582267
[TBL] [Abstract][Full Text] [Related]
15. Detection and confirmation of zilpaterol in equine hair using liquid chromatography-mass spectrometry.
Moeller BC; Clifford A; Emery RT; Alarcio G; Favro G; Arthur RM
Drug Test Anal; 2022 Jan; 14(1):31-38. PubMed ID: 34355536
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a hydrophilic interaction liquid chromatography with tandem mass spectrometry method for the simultaneous detection and quantification of etilefrine and oxilofrine in equine blood plasma and urine.
Kong N; Yi R; Zhao S; Sandhu J; Lam G; Loganathan D; Morrissey B
J Sep Sci; 2014 Nov; 37(21):3015-23. PubMed ID: 25143252
[TBL] [Abstract][Full Text] [Related]
17. High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography--Orbitrap mass spectrometry.
Ho EN; Kwok WH; Wong AS; Wan TS
Drug Test Anal; 2013 Jul; 5(7):509-28. PubMed ID: 22941912
[TBL] [Abstract][Full Text] [Related]
18. A sensitive HPLC-MS/MS method for the detection, resolution and quantitation of cathinone enantiomers in horse blood plasma and urine.
Loganathan D; Yi R; Patel B; Zhang J; Kong N
Anal Bioanal Chem; 2021 Mar; 413(8):2147-2161. PubMed ID: 33517480
[TBL] [Abstract][Full Text] [Related]
19. Implementation of the HIF activator IOX-2 in routine doping controls - Pilot study data.
Görgens C; Guddat S; Bosse C; Knoop A; Geyer H; Thevis M
Drug Test Anal; 2020 Nov; 12(11-12):1614-1619. PubMed ID: 32809277
[TBL] [Abstract][Full Text] [Related]
20. Use of Liquid Chromatography--Tandem Mass Spectrometry to Quantify and Confirm the Fentanyl Metabolite N-[1-(2-Phenethy-4-Piperidinyl)] Maloanilinic Acid in Equine Urine for Doping Control.
You Y; Proctor RM; Haughan J; Missanelli JR; Robinson MA
J Anal Toxicol; 2023 Apr; 47(4):393-402. PubMed ID: 36760176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
